语言版本

Time of issue:2021-09-02 16:56:33
搜索
Search
/
/
/
Fulvestrant
All categories
Number of views:
1000

Fulvestrant

FASLODEX is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Retail price
0.0
Market price
0.0
Number of views:
1000
No.
Category
API
Chemical Name:
7-α-[9-(4,4,5,5,5-penta fluoropentylsulphinyl) nonyl]estra-1,3,5-(10)- triene-3,17-beta-diol.
Molecular Formula:
C32H47F5O3S
Molecular Weight:
606.77
Therapeutic Classification:
Oncology
CAS:
129453-61-8
Registration File:
Quantity
-
+
Stock:
0
Detail
Parameters

FASLODEX is indicated for the treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.

Keyword:
treatment
disease
indicated
metastatic
in
for
progression
is
faslodex
Scan the QR code to read on your phone
We could not find any corresponding parameters, please add them to the properties table

RELATED WEBSITES

友情链接

Time of issue:2020-07-27 00:00:00
Online customer service
Customer service hotline
+86-023-67886928 +86-023-67886928
Service time:
8:30 - 17:30
Customer service group:
在线客服

地址版权

Time of issue:2019-05-10 00:00:00

© 2021 Chongqing Huapont Pharmaceutical Co., Ltd. All Rights Reserved.  渝ICP备2021007919号  1渝公网安备50011702500758号  Powered by:www.300.cn

地址版权手机

Time of issue:2019-05-10 00:00:00

© 2021 Chongqing Huapont Pharmaceutical Co., Ltd.

渝ICP备2021007919号  Powered by:www.300.cn

1渝公网安备50011702500758号